The mutation of CTNNB1 has been implicated in controlling tumor cell proliferation, differentiation, and progression, which due to its mutation, led to abnormal activation of the Wnt/β-catenin signaling pathway (37). The gene discussed is CTNNB1; the disease is neoplasm.